U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07181538) titled 'Phase 1 Study of JLP-2302 and JP-1366: PK and Safety in Healthy Volunteers' on Aug. 29.
Brief Summary: This study aims to evaluate the pharmacokinetics and the safety after administration of "JLP-2302" and "JP-1366" in healthy volunteers.
Study Start Date: Feb. 04
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: JLP-2302
taking JLP-2302
DRUG: JP-1366
taking JP-1366
Recruitment Status: COMPLETED
Sponsor: Onconic Therapeutics Inc.
Published by HT Digital Content Services with permission from Health Daily Digest....